Blinatumomab Pharmacodynamics and Exposure-Response Relationships in Relapsed/Refractory Acute Lymphoblastic Leukemia
Author:
Affiliation:
1. Clinical Pharmacology; Modeling and Simulation, Amgen Inc.; Thousand Oaks CA USA
2. Pharmacokinetics and Drug Metabolism; Amgen Research (Munich) GmbH; Munich Germany
3. Department of Global Biostatistical Science; Amgen Inc.; Washington DC USA
Funder
Amgen
Publisher
Wiley
Subject
Pharmacology (medical),Pharmacology
Reference21 articles.
1. Outcome of relapsed adult lymphoblastic leukemia depends on response to salvage chemotherapy, prognostic factors, and performance of stem cell transplantation;Gokbuget;Blood,2012
2. Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study;Fielding;Blood,2007
3. Defining the course and prognosis of adults with acute lymphocytic leukemia in first salvage after induction failure or short first remission duration;Kantarjian;Cancer,2010
4. Taking up cancer immunotherapy challenges: bispecific antibodies, the path forward?;Del Bano;Antibodies,2016
5. Extremely potent, rapid and costimulation-independent cytotoxic T-cell response against lymphoma cells catalyzed by a single-chain bispecific antibody;Dreier;Int J Cancer,2002
Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. In vivo expression of anti-CD19/CD3 BiTE by liver-targeted AAV for the treatment of B cell malignancies;2024-01-31
2. Mechanism-based pharmacokinetic and pharmacodynamic modeling for bispecific antibodies: challenges and opportunities;Expert Review of Clinical Pharmacology;2023-09-24
3. Harnessing the immunomodulatory effects of exercise to enhance the efficacy of monoclonal antibody therapies against B-cell haematological cancers: a narrative review;Frontiers in Oncology;2023-08-23
4. Development of a multiscale mechanistic modeling framework integrating differential cellular kinetics of CAR T‐cell subsets and immunophenotypes in cancer patients;CPT: Pharmacometrics & Systems Pharmacology;2023-08-18
5. Population dynamics of immunological synapse formation induced by bispecific T cell engagers predict clinical pharmacodynamics and treatment resistance;eLife;2023-07-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3